Breaking News Instant updates and real-time market news.

FB

Facebook

$130.24

1.25 (0.97%)

16:32
10/10/16
10/10
16:32
10/10/16
16:32

Facebook tests ads within Groups feature, TechCrunch says

Facebook has begun testing ads in its Groups feature, reports TechCrunch, citing spokesperson statements. "We have started to test delivering ads to people in Facebook Groups, and will be evaluating the response before determining how we will move forward," the company confirmed to TechCrunch, adding that the products will look the same as its News Feed ads. The publication notes that Facebook may be searching for new ways to increase ad load for the average user. Reference Link

  • 23

    Oct

  • 02

    Nov

  • 14

    Nov

FB Facebook
$130.24

1.25 (0.97%)

10/03/16
BARD
10/03/16
NO CHANGE
BARD
Baird says impact on eBay from Facebook's Marketplace likely limited for now
Baird analyst Colin Sebastian said Facebook's (FB) launch of its long-anticipated peer-to-peer commerce platform, "Marketplace," came "much later" than he anticipated, but he still thinks Facebook is well positioned to compete in consumer shopping. Facebook's latest e-commerce effort will create headlines around competitive pressure, but Sebastian thinks Amazon (AMZN) and eBay (EBAY) will be "minimally impacted" in the near term given their scale, brand awareness, and much more advanced e-commerce capabilities. eBay may be most exposed, but the analyst also notes that 80% of its listings are new products, which may have limited overlap with Facebook listings.
10/03/16
BOFA
10/03/16
NO CHANGE
Target $150
BOFA
Buy
BofA/Merrill remains positive on Facebook heading into Q3 report
BofA/Merrill remains positive on Facebook heading into the Q3 report based on strong engagement, pricing tailwinds, and advertiser growth. The firm's analyst rate shares a Buy with a $150 price target and sees potential for a Q3 beat.
10/04/16
PIPR
10/04/16
NO CHANGE
Target $185
PIPR
Overweight
Facebook issues at Marketplace launch a 'non-event,' says Piper Jaffray
Piper Jaffray analyst Gene Munster noted that after Facebook launched its new Marketplace offering on Monday that some users listed prohibited items, such as guns and drugs, that were not caught as they should have been by the company's filter. However, he views the misstep at launch as a "non-event" and thinks nothing has changed in term of Facebook's ability to build world-class products and go after new markets. Munster keeps an Overweight rating and $185 price target on Facebook shares.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Alphabet, Facebook can meet Street estimates, says Wells Fargo
Wells Fargo says that investors are concerned about the ability of Facebook (FB) and Google (GOOG,GOOGL) to meet Street estimates because forecasts continue to indicate that TV's ad share will be relatively stable over the next two years. But Wells says that Facebook and Google will continue to gain share from "non-TV media" and could see increased revenue from "non-advertising marketing services" such as sponsorships and public relations. Wells keeps Outperform ratings on both stocks.

TODAY'S FREE FLY STORIES

DHT

DHT Holdings

$4.60

-0.05 (-1.08%)

07:07
04/24/17
04/24
07:07
04/24/17
07:07
Hot Stocks
DHT Holdings announces delivery of two VLCCs from BW Group »

DHT Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFR

Colony Starwood Homes

$34.82

0.12 (0.35%)

07:07
04/24/17
04/24
07:07
04/24/17
07:07
Initiation
Colony Starwood Homes initiated  »

Colony Starwood Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 15

    May

AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

, PPG

PPG

$105.94

-0.43 (-0.40%)

07:06
04/24/17
04/24
07:06
04/24/17
07:06
Hot Stocks
AkzoNobel says will 'carefully review' PPG's third unsolicited proposal »

Akzo Nobel N.V. (AKZOY)…

AKZOY

AkzoNobel

$27.96

-0.11 (-0.39%)

PPG

PPG

$105.94

-0.43 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLYA

Playa Hotels & Resorts

$10.26

-0.04 (-0.39%)

07:06
04/24/17
04/24
07:06
04/24/17
07:06
Initiation
Playa Hotels & Resorts initiated  »

Playa Hotels &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

FLR

Fluor

$50.58

0.09 (0.18%)

, BP

BP

$34.00

-0.15 (-0.44%)

07:06
04/24/17
04/24
07:06
04/24/17
07:06
Hot Stocks
Fluor awarded offshore compression platform FEED by BP »

Fluor (FLR) announced…

FLR

Fluor

$50.58

0.09 (0.18%)

BP

BP

$34.00

-0.15 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

PRTK

Paratek Pharmaceuticals

$22.00

0.4 (1.85%)

07:05
04/24/17
04/24
07:05
04/24/17
07:05
Hot Stocks
Paratek, Zai Lab announce collaboration for Omadacycline in China »

Paratek Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTK

Paratek Pharmaceuticals

$22.00

0.4 (1.85%)

07:04
04/24/17
04/24
07:04
04/24/17
07:04
Hot Stocks
Paratek highlights potential for omadacycline to provide cost savings vs. SOC »

Paratek Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWLD

Buffalo Wild Wings

$161.75

-2 (-1.22%)

07:04
04/24/17
04/24
07:04
04/24/17
07:04
Hot Stocks
Buffalo Wild Wings announces filing of proxy materials »

Buffalo Wild Wings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

GWW

Grainger

$195.15

-0.81 (-0.41%)

07:04
04/24/17
04/24
07:04
04/24/17
07:04
Downgrade
Grainger rating change  »

Grainger downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 19

    Jul

  • 17

    Oct

  • 24

    Jan

ATEC

Alphatec

, CAE

CAE

$15.21

-0.06 (-0.39%)

07:04
04/24/17
04/24
07:04
04/24/17
07:04
Conference/Events
American Association of Neurological Surgeons to hold annual meeting »

2017 AANS Annual…

ATEC

Alphatec

CAE

CAE

$15.21

-0.06 (-0.39%)

EDGE

Edge Therapeutics

$9.02

-0.02 (-0.22%)

MDT

Medtronic

$80.48

-0.54 (-0.67%)

NUVA

NuVasive

$75.02

-0.68 (-0.90%)

SYK

Stryker

$132.94

0.18 (0.14%)

VRTX

Vertex

$116.70

-0.56 (-0.48%)

SYNA

Synaptics

$50.76

-0.34 (-0.67%)

NVIV

InVivo Therapeutics

$3.90

-0.35 (-8.24%)

LMAT

LeMaitre

$25.14

-0.23 (-0.91%)

MZOR

Mazor Robotics

$35.68

0.64 (1.83%)

OFIX

Orthofix

$38.95

0.33 (0.85%)

SSNLF

Samsung

SIEGY

Siemens

$67.34

-0.197 (-0.29%)

SNE

Sony

$33.68

0.85 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 03

    May

  • 18

    May

  • 24

    May

  • 25

    May

  • 06

    Jun

AMRI

Albany Molecular

$15.82

0.04 (0.25%)

07:04
04/24/17
04/24
07:04
04/24/17
07:04
Hot Stocks
Denovo obtains license to Albany Molecular's liafensine »

Denovo Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

OPB

Opus Bank

$20.80

0.6 (2.97%)

07:03
04/24/17
04/24
07:03
04/24/17
07:03
Earnings
Opus Bank reports Q1 EPS ex-items 24c, consensus 27c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 15

    May

PRTK

Paratek Pharmaceuticals

$22.00

0.4 (1.85%)

07:03
04/24/17
04/24
07:03
04/24/17
07:03
Hot Stocks
Paratek: Omadacycline 'effective' against most common skin infections, MRSA »

Paratek Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$79.28

-0.15 (-0.19%)

07:02
04/24/17
04/24
07:02
04/24/17
07:02
Recommendations
CVS Health analyst commentary  »

JPMorgan a buyer of CVS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 10

    May

MTNB

Matinas BioPharma

$2.93

0.06 (2.09%)

07:02
04/24/17
04/24
07:02
04/24/17
07:02
Hot Stocks
Matinas BioPharma presents 'positive' preclinical data of DNA vaccines at ECCMID »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

PDLI

PDL BioPharma

$2.02

-0.03 (-1.46%)

, MRK

Merck

$61.89

-0.66 (-1.06%)

07:02
04/24/17
04/24
07:02
04/24/17
07:02
Hot Stocks
PDL BioPharma settles Keytruda patent infringement suit with Merck »

PDL BioPharma (PDLI)…

PDLI

PDL BioPharma

$2.02

-0.03 (-1.46%)

MRK

Merck

$61.89

-0.66 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 07

    May

  • 10

    May

  • 27

    May

  • 09

    Jun

  • 09

    Jun

  • 14

    Jun

ERII

Energy Recovery

$8.18

0.03 (0.37%)

07:01
04/24/17
04/24
07:01
04/24/17
07:01
Hot Stocks
Energy Recovery awareded $3M in orders for its PXTM technology »

Energy Recovery announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDHL

RedHill Biopharma

$10.38

0.41 (4.11%)

07:01
04/24/17
04/24
07:01
04/24/17
07:01
Hot Stocks
RedHill Biopharma announces enrollment of last patient in Bekinda Phase II study »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

NVS

Novartis

$73.40

-0.22 (-0.30%)

, LLY

Eli Lilly

$81.89

-0.05 (-0.06%)

07:00
04/24/17
04/24
07:00
04/24/17
07:00
Periodicals
Novartis tests Alzheimer's drugs on people who don't yet have disease, WSJ says »

Novartis (NV) is testing…

NVS

Novartis

$73.40

-0.22 (-0.30%)

LLY

Eli Lilly

$81.89

-0.05 (-0.06%)

AMGN

Amgen

$160.41

-1.63 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 07

    May

  • 06

    Jun

  • 26

    Jun

  • 19

    Jul

  • 14

    Aug

SONC

Sonic

$24.91

0.63 (2.59%)

06:59
04/24/17
04/24
06:59
04/24/17
06:59
Upgrade
Sonic rating change  »

Sonic upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

ADI

Analog Devices

$77.63

-1.03 (-1.31%)

06:59
04/24/17
04/24
06:59
04/24/17
06:59
Upgrade
Analog Devices rating change  »

Analog Devices upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

APTS

Preferred Apartment

$14.29

0.05 (0.35%)

06:57
04/24/17
04/24
06:57
04/24/17
06:57
Hot Stocks
Preferred Apartment acquires 80,018 square foot shopping center in Atlanta »

Preferred Apartment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

MDEVF

Melco International

06:56
04/24/17
04/24
06:56
04/24/17
06:56
Downgrade
Melco International rating change  »

Melco International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AU

AngloGold

$12.43

-0.08 (-0.64%)

06:53
04/24/17
04/24
06:53
04/24/17
06:53
Downgrade
AngloGold rating change  »

AngloGold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFI

Gold Fields

$3.84

-0.08 (-2.04%)

06:53
04/24/17
04/24
06:53
04/24/17
06:53
Downgrade
Gold Fields rating change  »

Gold Fields downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.